StonvexLoading…
StonvexStonvexStonvexCore line items from KTOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-29 | Annual 2023 2023-12-31 | Annual 2022 2022-12-25 |
|---|---|---|---|---|
Revenue | $1.35B | $1.14B | $1.04B | $898.30M |
Operating Income | $25.60M | $29.00M | $31.10M | $-2.90M |
Net Income | $22.00M | $16.30M | $-8.90M | $-36.90M |
EPS (Diluted) | $0.13 | $0.11 | $-0.07 | $-0.29 |
Total Assets | $2.47B | $1.95B | $1.63B | $1.55B |
Total Liabilities | $470.90M | $597.70M | $634.00M | $604.00M |
Cash & Equivalents | $560.60M | $329.30M | $72.80M | $81.30M |
Free Cash Flow OCF − CapEx | $-137.40M | $-8.50M | $12.80M | $-71.10M |
Shares Outstanding | 168.88M | 151.09M | 129.29M | 125.99M |